Clinical Efficacy of Conventional Heparin Anticoagulation Combined with Apixaban in the Treatment of Patients with Cerebral Venous Thrombosis and Its Effect on Serum D-Dimer and FIB Expression
Table 1
Comparison of clinical data between the two groups ( (%)).
Standard group ()
Research group ()
/t
Gender
0.045
0.833
Male
43 (45.26)
27 (43.55)
Female
52 (54.74)
35 (56.45)
Age (years old)
2.860
0.582
<30
11 (11.58)
8 (12.90)
30-39
25 (26.31)
10 (16.13)
40-49
30 (31.58)
22 (35.48)
50-59
14 (14.74)
13 (20.97)
≥60
15 (15.79)
9 (14.52)
Diagnostic method
3.502
0.321
CT combined with ductography
58 (61.05)
32 (51.61)
MRI combined with ductography
24 (25.26)
24 (38.71)
CT combined with CT venography
5 (5.26)
3 (4.84)
MRI combined with MR venography
8 (8.42)
3 (4.84)
Admission time (d)
1.786
0.076
Time of diagnosis (d)
1.386
0.168
Hospitalization time (d)
0.693
0.490
Symptoms
1.483
0.686
Aphasia
21 (22.11)
10 (16.13)
Dyskinesia
28 (29.47)
23 (37.10)
Mental disorder
16 (16.84)
9 (14.52)
Intracranial hypertension
30 (31.53)
20 (32.26)
Headache
88
39
Deep vein thrombosis
0.209
0.648
Yes
10 (10.53)
8 (12.90)
No
85 (89.47)
54 (87.10)
GCS score
1.312
0.519
13-15
64
46
9-12
18
11
≤8
13
5
Infection
2.026
0.155
Yes
17 (17.89)
6 (9.68)
No
78 (82.11)
56 (90.32)
C-reactive protein (mg/L)
0.215
0.830
Homocysteine (μmol/L)
0.098
0.923
Drinking
0.993
0.319
Yes
49 (51.58)
37 (59.68)
No
46 (48.42)
25 (40.32)
Smoking
0.338
0.561
Yes
43 (45.26)
31 (50.00)
No
52 (54.74)
31 (50.00)
GCS: Glasgow Coma Scale; CT: computed tomography; MRI: magnetic resonance.
